Bharat Biotech completes Covaxin trials for children
September 21, 2021
625
9
1.44%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Mirror Now Episodes Around September 21, 2021
See what was published immediately before and after this episode.
1:40Now PlayingBharat Biotech completes Covaxin trials for children
YouTube Description
as posted by the channelBharat Biotech has completed the Phase 2 and 3 clinical trials of its vaccine against the coronavirus- Covaxin for use in the age group of 2 to 18 years. The Hyderabad-based company will be submitting the data by next week to the Drugs Controller General of India. Currently the data analysis is underway. After submitting the data, the company may be asked to give its presentation and it will take approximately a months time for the DCGI to reveiw the data report submitted by the vaccine maker before amking a decision. Watch the full report here! Stay tuned for more updates with Mirror Now.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.









